SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-093256
Filing Date
2021-03-25
Accepted
2021-03-25 06:03:38
Documents
4
Period of Report
2021-05-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A d102887ddef14a.htm DEF 14A 301737
2 GRAPHIC g102887g09k68.jpg GRAPHIC 23841
3 GRAPHIC g102887pc1.jpg GRAPHIC 141455
4 GRAPHIC g102887pc2.jpg GRAPHIC 159374
  Complete submission text file 0001193125-21-093256.txt   746788
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: DEF 14A | Act: 34 | File No.: 001-39398 | Film No.: 21770008
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences